Discusses pregnancy testing, contraception, and potential infertility risks. Safety Principles During Pregnancy Pregnancy and Lactation Labeling Final Rule - FDA
For detailed, authoritative guidance, you can access comprehensive resources such as the or the World Health Organization (WHO) Guide on Breastfeeding and Maternal Medication . Understanding the Regulatory Landscape: PLLR drugs in pregnancy and lactation pdf free download
The FDA replaced the old "A, B, C, D, X" letter categories with the . This rule requires drug manufacturers to provide a descriptive "Risk Summary" and "Clinical Considerations" section in their labeling to help providers make more nuanced decisions. This rule requires drug manufacturers to provide a
Includes information on exposure registries, maternal and fetal risks, and labor/delivery. maternal and fetal risks
Details drug presence in breast milk, effects on the nursing infant, and impacts on milk production.
Navigating medication safety during pregnancy and lactation is a critical task for both healthcare providers and expecting parents. Because many clinical trials historically excluded these populations, reliable information often comes from observational data and specialized registries.